No, GLP-1 receptor agonists are not licensed for rheumatoid arthritis in the UK
Retatrutide produced remarkably predictable outcomes, with 87% of those who made it past week 12 achieving at least 15% total weight loss
MOTS-c Interactions with Common Medications Does MOTS-c interact with your medications
HSPA1, heat shock protein family A member 1
Because AMY receptors also interact with calcitonin, dual amylin/calcitonin receptor agonists (DACRAs) have been developed, with preclinical studies finding greater weight loss than with amylin analogues alone, and additional efficacy in combination with a GLP-1RA [70]
Tirzepatide was the first dual GLP-1/GIP agonist to reach approval, and the published SURMOUNT-1 trial showed that adding GIP to GLP-1 produces additive metabolic effects